Help the refugees

If you move around the world by choice, consider helping those forced from their homes by conflict. Donate to the UN Refugee Agency today.

Home News Generic drugs in Switzerland cost 52% more than in Europe

Generic drugs in Switzerland cost 52% more than in Europe

Published on 31/05/2018

The price of generic drugs in Switzerland in 2017 was 52% higher than the average of nine other European countries, says a study. Patented drugs were 9% more expensive.

The study, published on Thursday, examined the prices of 250 best-selling patent-protected original medications, generic drugs and medications whose patent had expired. It was conducted for the ninth time by the association of research-based pharmaceutical companies Interpharma and the Swiss health insurance association Santésuisse.

Compared with the previous survey in 2016, the price difference of generic drugs has remained virtually unchanged. Generic medications were 52% more expensive in Switzerland than in selected European countries in 2017, compared with 53% the previous year.

The price difference of patented drugs decreased slightly in 2017, down from 14% the previous year. The reasons for the drop were exchange rate fluctuations as well as last year’s price review, which reduced the price of over 400 drugs in Switzerland.

Original drugs whose patent had expired were 17% more expensive than in the other European countries, compared with a 20% mark-up in 2016, according to the survey.

The comparison countries were Belgium, Denmark, Germany, Finland, France, Britain, the Netherlands, Austria and Sweden.